TrialLeukemia & lymphoma2010

Report of a phase 1/2 study of a combination of azacitidine and cytarabine in acute myelogenous leukemia and high-risk myelodysplastic syndromes.

Gautam Borthakur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.